NCT01368614 - AVAPS-AE Efficacy Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2011

Primary Completion Date

May 30, 2013

Study Completion Date

May 30, 2013

Conditions

Obesity Hypoventilation Syndrome

Interventions

DEVICE

AVAPS-AE Mode of Therapy

AVAPS-AE mode is the experimental mode of therapy in this study that includes a combination of already cleared therapy attributes.

DEVICE

Respironics OnmiLab BiPAP S mode

Currently cleared Non-Invasive Ventilation (NIV) therapy modality

DEVICE

Respironics OmniLab Advanced CPAP mode

Currently cleared NIV therapy modality

Trial Locations (2)

University of Chicago, Chicago

University of Arizona School of Medicine, Tucson